Lumjeb injection 100 units/mL is an ultra-rapid-acting insulin lispro (recombinant) medication by Eli Lilly Japan, designed for managing diabetes mellitus in adults, adolescents, and children aged 1 year and above. It comes as a 100 units/mL, 1mL vial (YJ code: 2492414A6028) and is typically injected subcutaneously just before or shortly after starting a meal.
Lumjeb injection 100 units/mL
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →